We have been advised that fraudulent emails and faxes regarding unclaimed insurance money have been received by members of the public from a source claiming to be Aird & Berlis LLP. These communications are not from Aird & Berlis LLP. Disregard them and do not engage with the sender in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre.

Back to all Representative Matters
Oct 10, 2018

MediPharm Labs Corp. Completes Qualifying Transaction and Commences Trading on the TSXV

Melanie Cole and Amy Marcen-Gaudaur

On October 1, 2018, MediPharm Labs Corp. (formerly POCML 4 Inc.) (TSXV: LABS) (“MediPharm Labs” or the “Company”) completed its business combination with MediPharm Labs Inc. (the “Target”), which resulted in a reverse take-over of the Company by the shareholders of the Target and constituted the “Qualifying Transaction” of the Company as such term is defined in the policies of the TSX Venture Exchange (the “TSXV”). On October 4, 2018, the shares of MediPharm Labs began trading on the TSXV under the ticker symbol “LABS”.

MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its Australian subsidiary, MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.

Aird & Berlis LLP represented MediPharm with a team comprised of Melanie Cole, Daniel Everall and Amy Marcen-Gaudaur (capital markets) and Brandon Church (corporate services).

Areas of Expertise

Related Industries

Related Representative Matters

Representative Matters
Pistil Partners Completes Financing and Strategic Acquisition Sherri M. Altshuler, Melanie Cole, Amy Marcen-Gaudaur and Meredith McCann Oct 21, 2019 Pistil Partners Inc. completed a private placement of its common shares and acquisition of Ironside Hemp Company Inc., a private U.S.-based hemp management company.
Representative Matters
Allied Properties REIT Completes $300 Million Debt Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Meredith McCann, Michael D. Smith, Neill Kalvin, Zale Skolnik and Barbara Worndl Oct 09, 2019 Allied Properties Real Estate Investment Trust recently completed a $300 million debt offering of 3.113% series E senior unsecured debentures.
Representative Matters
Thar Process Completes US$10 Million Non-Brokered Private Placement Richard M. Kimel, Adria Leung Lim and Russell J. Sanders Sep 20, 2019 Thar is a U.S.-based provider of CO2 extraction and purification solutions for the hemp and cannabis industries.